(Q45369516)

13 December 2017

title

Studies on virus kinetics using infectious fluorescence-tagged hepatitis C virus cell culture (English)

1 reference

13 December 2017

hepatitis C virus

1 reference

9

1 reference

13 December 2017

12

Mamoru Watanabe

1 reference

13 December 2017

Machi Yamamoto

1

1 reference

13 December 2017

Naoya Sakamoto

2

1 reference

13 December 2017

Tetsuya Nakamura

3

1 reference

13 December 2017

Yasuhiro Itsui

4

1 reference

13 December 2017

Mina Nakagawa

5

1 reference

13 December 2017

Yuki Nishimura-Sakurai

6

1 reference

13 December 2017

Sei Kakinuma

7

1 reference

13 December 2017

Seishin Azuma

8

1 reference

13 December 2017

Takanobu Kato

10

1 reference

13 December 2017

Takaji Wakita

11

1 reference

13 December 2017

publication date

30 January 2011

1 reference

13 December 2017

1 reference

13 December 2017

volume

41

1 reference

13 December 2017

issue

3

1 reference

13 December 2017

page(s)

258-269

1 reference

The natural history of compensated cirrhosis due to hepatitis C virus: A 17-year cohort study of 214 patients

13 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2010.00771.X

Impact of amino acid substitutions in the core region of HCV on multistep hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2010.00771.X

lambda-Interferons and the single nucleotide polymorphisms: A milestone to tailor-made therapy for chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2010.00771.X

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2010.00771.X

Peginterferon alfa-2a in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2010.00771.X

New therapeutic approaches to hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2010.00771.X

Replication of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2010.00771.X

Hepatitis C virus nonstructural proteins are localized in a modified endoplasmic reticulum of cells expressing viral subgenomic replicons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2010.00771.X

Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2010.00771.X

Production of infectious hepatitis C virus in tissue culture from a cloned viral genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2010.00771.X

Insertion of green fluorescent protein into nonstructural protein 5A allows direct visualization of functional hepatitis C virus replication complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2010.00771.X

A cell-based, high-throughput screen for small molecule regulators of hepatitis C virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2010.00771.X

Analysis of Hepatitis C Virus Superinfection Exclusion by Using Novel Fluorochrome Gene-Tagged Viral Genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2010.00771.X

Mobility analysis of an NS5A-GFP fusion protein in cells actively replicating hepatitis C virus subgenomic RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2010.00771.X

Interaction of Hepatitis C Virus Nonstructural Protein 5A with Core Protein Is Critical for the Production of Infectious Virus Particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2010.00771.X

Compensatory mutations in NS3 and NS5A proteins enhance the virus production capability of hepatitis C reporter virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2010.00771.X

An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2010.00771.X

In vitro activity and preclinical profile of TMC435350, a potent hepatitis C virus protease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2010.00771.X

Robust hepatitis C virus infection in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2010.00771.X

Development of plaque assays for hepatitis C virus-JFH1 strain and isolation of mutants with enhanced cytopathogenicity and replication capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2010.00771.X

Two flavonoids extracts from Glycyrrhizae radix inhibit in vitro hepatitis C virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2010.00771.X

A reporter cell line for rapid and sensitive evaluation of hepatitis C virus infectivity and replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2010.00771.X

Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2010.00771.X

10.1111/J.1872-034X.2010.00771.X

21 January 2018

Identifiers

DOI

1 reference

13 December 2017

1 reference